EVIAGENICS concluded the sale of its Flavonoid Biotech platform to Alderys, a well-established French Biotech firm located at Orsay Link to the Official Press Release Link to the “Formule verte” article Link to the “Nutra-ingredients”...
EVIAGENICS concluded in June 2015 the sale of its yeast based Vanillin technology (and related patents) to a large industrial player. The terms and conditions of this transaction are confidential. Algaia is now concentrating its Biotech R&D efforts to specific...
GELYMAR enters into a commercial and development agreement with EVIAGENICS in Europe regarding seaweed extracts. Andres Hohlberg (Gelymar CEO) and Fabrice Bohin (EVIAGENICS CEO) January 22nd 2015: GELYMAR, a Chilean company currently being one of the top 4 global...
EVIAGENICS selected for PM’up regional grant. The purpose of this grant is to support the development of the Paris region SMB with high growth potential. The region selects projects with the greatest potential for value creation, employment, international development...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
